1. Home
  2. MDXH vs BMGL Comparison

MDXH vs BMGL Comparison

Compare MDXH & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • BMGL
  • Stock Information
  • Founded
  • MDXH 2003
  • BMGL 2001
  • Country
  • MDXH Belgium
  • BMGL Singapore
  • Employees
  • MDXH N/A
  • BMGL N/A
  • Industry
  • MDXH
  • BMGL
  • Sector
  • MDXH
  • BMGL
  • Exchange
  • MDXH Nasdaq
  • BMGL NYSE
  • Market Cap
  • MDXH 73.3M
  • BMGL 75.9M
  • IPO Year
  • MDXH 2021
  • BMGL 2025
  • Fundamental
  • Price
  • MDXH $1.46
  • BMGL $5.00
  • Analyst Decision
  • MDXH Buy
  • BMGL
  • Analyst Count
  • MDXH 1
  • BMGL 0
  • Target Price
  • MDXH $6.00
  • BMGL N/A
  • AVG Volume (30 Days)
  • MDXH 88.1K
  • BMGL 120.4K
  • Earning Date
  • MDXH 04-30-2025
  • BMGL 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • BMGL N/A
  • EPS Growth
  • MDXH N/A
  • BMGL 16.23
  • EPS
  • MDXH N/A
  • BMGL 0.09
  • Revenue
  • MDXH $90,049,000.00
  • BMGL $7,428,776.00
  • Revenue This Year
  • MDXH $23.38
  • BMGL N/A
  • Revenue Next Year
  • MDXH $16.84
  • BMGL N/A
  • P/E Ratio
  • MDXH N/A
  • BMGL $51.86
  • Revenue Growth
  • MDXH 28.29
  • BMGL 3.32
  • 52 Week Low
  • MDXH $1.35
  • BMGL $3.75
  • 52 Week High
  • MDXH $3.50
  • BMGL $5.40
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 36.94
  • BMGL N/A
  • Support Level
  • MDXH $1.55
  • BMGL N/A
  • Resistance Level
  • MDXH $1.66
  • BMGL N/A
  • Average True Range (ATR)
  • MDXH 0.08
  • BMGL 0.00
  • MACD
  • MDXH 0.00
  • BMGL 0.00
  • Stochastic Oscillator
  • MDXH 21.84
  • BMGL 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About BMGL BASEL MEDICAL GROUP LTD

Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.

Share on Social Networks: